H ypertension imparts an increased risk of myocardial infarction, stroke, renal damage, and blindness. 1 Although at least10 genes have been shown to increase blood pressure, the pathogenesis of steroid hypertension has been shown to be primarily linked to mutations that result in ectopic production of the adrenal corticosterone, or aldosterone. 2 Hypertension has also been shown to have proinflammatory actions, which increase the formation of hydrogen peroxide (H 2 O 2 ) and superoxide (O 2 Ϫ ) within tissue and blood. [3] [4] [5] Furthermore, superoxide accumulation has been implicated in the activation of nuclear factor-B (NF-B). 6 NF-B transcriptionally regulates many cellular genes implicated in early immune, acute phase, and inflammatory responses, including interleukin (IL)-1␤, tumor necrosis factor-␣, IL-2, IL-6, IL-8, inducible NO synthase (iNOS), cyclooxygenase (COX)-2, intracellular adhesion molecules, and many antioxidant systems. 7 Free radicals and other reactive oxygen species (ROS) are generated by all aerobic cells and have been shown to participate in many deleterious reactions, in particular, reduced formation of endothelial NO synthase (eNOS) 8, 9 and increased oxidative stress. 10 Endogenous NO plays an important role in the regulation of blood pressure by maintaining vascular smooth muscle in a partially relaxed state. During hypertension, the endogenous vasodilatory effect of NO is prevented due to interaction with ROS, specifically superoxide, thus resulting in increased vascular resistance and elevation of blood pressure. 3, 11, 12 Antioxidant treatment has been shown to have beneficial effects on NO metabolism and the pathogenesis observed in angiotensin (Ang) II 13 -and lead 14 -induced hypertension. In vivo and in vitro studies have shown that pyrrolidinedithiocarbamate (PDTC) is a potent antioxidant and NF-B antagonist. 9, 13, 15 Furthermore, Ang II-receiving rats treated with PDTC exhibit decreased systolic blood pressure and partial amelioration of end-organ damage. 13 In other studies, the antioxidant Tempol (4-hydroxy-2,2,6,6-tetramethyl piperidinoxyl) has been shown to normalize blood pressure in spontaneously hypertensive rats (SHR). 16 Tempol is a membrane-stable, membrane-permeable, metal-independent superoxide dismutase (SOD) mimetic that has been shown to be specific for superoxide. 16 -18 To date, ROS accumulation has been reported in deoxycorticosterone acetate (DOCA)-salt hypertension, 3 SHR and stroke-prone spontaneously hypertensive rats (SHRSP), 5 lead-induced hypertension, 13 and essential hypertension. 19 Previously, we reported that mineralocorticoid hypertensive rats developed increased superoxide formation compounded with increased renal monocyte/ macrophage infiltration and NF-B activation. 20 We therefore tested the hypothesis that prolonged antioxidant administration inhibits superoxide accumulation, lowers systolic blood pressure, and reduces NF-B activation in mineralocorticoid hypertensive rats.
Methods
Silastic was from Dow Corning. DOCA, PMSF, dithiothreitol (DTT), Lucigenin, EDTA, and protease inhibitor cocktail were from Sigma Chemical Co. Pentobarbital was from The Butler Company. Ketamine and xylazine were from Fort Dodge Animal Health. Monocyte/macrophage ED-1 antibody was from Serotec. Tyramide signal amplification (TSA) kit was from NEN Life Science. Mouse HRP␣ and streptavidin-FITC were from Jackson ImmunoResearch.
DOCA-Salt Rats
Experiments were conducted on male Sprague-Dawley rats treated with mineralocorticoid for 28 days. All procedures were performed according to institutional guidelines. Male Sprague-Dawley rats were anesthetized with an intramuscular injection of 100 mg/kg ketamine/20 mg/kg xylazine. A midscapular incision was made, and a Silastic sheet containing DOCA (200 mg/kg body wt) was inserted subcutaneously. A right flank incision was made, and a uninephrectomy was performed. Rats treated with DOCA alone received 1% NaCl and 0.1% KCl in drinking water, whereas 10 DOCA-treated rats received drinking water with 1 mmol/L Tempol,1% NaCl, and 0.1% KCl. Ten DOCA-treated rats also received PDTC (200 mg/kg body wt IP) and were given drinking water that contained 1% NaCl and 0.1% KCl. These concentrations of Tempol and PDTC have been shown to effectively reduce oxidative stress and NF-B activation in intact rats. 13, 16 Sham-operated rats underwent nephrectomy without the implantation of a Silastic/DOCA pellet. Twentyeight days after implantation, blood pressure was measured with the tail cuff method (pneumatic transducer), and the rats were anesthetized with a ketamine/xylazine cocktail. The kidney and aorta was carefully removed, cleaned of excess fat, and placed in PSS composed of (mmol/L) NaCl 130, KCl 4.7, KH 2 PO 4 1.18, MgSO 4 -7H 2 O 1.17, NaHCO 3 14.9, dextrose 5.5, EDTA 0.26, and CaCl 2 1.6. The kidney was sectioned into 1-to 2-mm slices, and the aorta was cut into 2-to 3-mm rings.
Lucigenin Assay
Lucigenin chemiluminescence was used to measure superoxide production. Details of this assay have been published previously. 21, 22 In recent studies, 5 mol/L lucigenin has been shown to correlate well with electron spin resonance as a quantitative measure of superoxide production. 23, 24 After preparation, aortic sections were placed in PSS and allowed to equilibrate for 30 minutes at 37°C. Scintillation vials that contained 2 mL PSS buffer with 5 mol/L lucigenin were placed into a scintillation counter (Beckman LS 6000IC) and switched to out-of-coincidence mode. After dark adaptation, background counts were recorded and aortic rings were added to the vial. Scintillation counts were recorded every minute for 20 minutes, and counts between the 15-to 20-minute interval were averaged. Sections were dried in an oven for 24 hours, and counts were expressed as counts above background per milligram of dried tissue. Figure 1 . A, Systolic blood pressure in DOCA-salt hypertensive rats was significantly higher compared with sham-operated rats. When DOCA rats were treated with PDTC and Tempol, a significant decrease in systolic blood pressure was observed compared with untreated DOCA rats. Renal hypertrophy index was significantly greater in DOCA rats compared with sham rats. Treatment with PDTC and Tempol caused a significantly decrease in renal hypertrophy compared with rats treated with DOCA alone (B). Aortic superoxide production was substantially increased in DOCA rat aorta compared with sham-operated rats. Treatment with PDTC and Tempol caused a significant decrease in superoxide counts compared with untreated DOCA rats and no significant difference compared with sham rats (C). Results are expressed as meanϮSD of 7 to 24 rats per group. *PϽ0.05 vs sham. ␦PϽ0.05 vs DOCA.
Immunohistochemistry
Frozen kidneys were cryosectioned at 7-m thickness and air dried as previously described. 13 Sections were fixed with cold acetone, washed with PBS, blocked with blocking buffer (3% calf serum, 0.1% Tween 20, 1ϫ PBS), and incubated for 60 minutes in a humid chamber at room temperature with primary monoclonal anti-rat monocyte/macrophage ED-1 (1:250 in blocking buffer). After a 60-minute incubation, sections were washed with PBS and incubated with bridging peroxidase-conjugated antibody (HRP␣Mouse; 1:5000 in blocking buffer) for 30 minutes. Sections were then washed, and TSA was performed for 4 minutes according to a modification of the manufacturer's protocol. The tyramide was detected with Streptavidin-FITC 1:100 through incubation for 1 hour followed by washing. Immunoreactivity was visualized with a Ziess Axioplan 2 microscope, and photographs were taken with Zeiss Axiocam. Ten different sections of each kidney (5 kidneys per group) were analyzed. ED-1-abeled monocytes/macrophages from anatomically equivalent sections of each kidney were counted by an outside observer who was blinded as to treatment.
Electrophoretic Mobility Shift Assay
Tissue extractions and electrophoretic mobility shift assay (EMSA) for the transcription factor NF-B were performed as described previously. 25, 26 Kidneys were frozen and divided into 0.2-g sections. Kidney sections were pulverized in liquid nitrogen with a stainless steel mortar and pestle and resuspended in 1.5 mL hypotonic buffer containing protease inhibitor cocktail composed of (mmol/L) 10 mmol/L HEPES-KOH, pH 7.9, 10 mmol/L KCl, 1.5 mmol/L MgCl 2 , 0.5 mmol/L DTT, and protease inhibitor cocktail in a glass homogenizer, followed by incubation for 15 minutes on ice. The tissue was homogenized with 10 strokes in the presence of 1% NP-40. The suspension was centrifuged (13 600g, 4 minutes, 4°C), and the pellet was washed with 1 mL hypotonic buffer. The suspension was recentrifuged (13 600g, 4 minutes, 4°C), and the pellet was resuspended in salt solution (20 mmol/L HEPES-KOH, pH 7.9, 25% glycerol, 1.5 mmol/L MgCl 2 , 400 mmol/L KCl, 2 mmol/L EDTA, 0.5 mmol/L DTT, 0.5 mmol/L PMSF, and protease inhibitor cocktail). The salt suspension containing glass beads was rotated on a tube rotator (Sepco Scientific Equipment) for 30 minutes and centrifuged (20 000g, 30 minutes, 4°C) . The sample was Subsequently, the free and the oligonucleotide-bound proteins were separated with electrophoresis on a native 5.5% polyacrylamide gel in 0.5ϫ Tris borate-EDTA buffer. After electrophoresis, the gel was dried and exposed to Hyperfilm MP. The intensity of the bands was analyzed with a PhosphorImager (Molecular Dynamics). Competition experiments were conducted by adding excess unlabeled NF-B oligonucleotide to the binding reaction mixture. 
Statistical Analysis
Data are presented as meanϮSEM. Statistically significant differences among groups were tested by ANOVA and the Tukey multiple range test or t test as appropriate. A value of PϽ0.05 was considered statistically significant.
Results
Treatment with the antioxidants PDTC or Tempol reduced systolic blood pressure in DOCA rats (130Ϯ5 and 142Ϯ5 mm Hg versus 199Ϯ3 mm Hg, respectively; 24 DOCA, 12 DOCA/PDTC, and 7 DOCA/Tempol; PϽ0.05) ( Figure 1A) . However, the magnitude of the reduction in blood pressure did not reach that observed in sham rats (113Ϯ2 mm Hg, PϽ0.05; 13 sham) ( Figure 1A Figure 1B) .
As a means of measuring oxidative stress within the 4 treatment groups, we measured aortic superoxide production with lucigenin chemiluminescence. DOCA rat aorta had markedly increased superoxide production compared with sham rats (7153 versus 783 versus 3055Ϯ559 cpm/mg, 14 and 12, respectively) ( Figure 1C) . Treatment of DOCA rats with PDTC or Tempol markedly decreased superoxide production compared with untreated DOCA rats (2498Ϯ251 and 2939Ϯ469 versus 7153Ϯ783, respectively; PϽ0.05) ( Figure  1C ). There was no significant difference in PDTC-or Tempol-treated rats compared with sham rats (2498Ϯ251 and 2939Ϯ469 versus 3055Ϯ559 cpm/mg; 8, 8, and13, respectively; PϾ0.05) ( Figure 1C) .
We further investigated monocyte and macrophage infiltration in renal tissue. Monocyte/macrophage infiltration was localized mainly in the renal tubules (Figure 2 ). DOCA rats exhibited increased monocyte/macrophage infiltration compared with sham rats (42Ϯ5 versus 10Ϯ2 per field viewed; 5 in all groups, respectively; PϽ0.05) (Figures 2A, 2B , and 2E). DOCA rats treated with PDTC or Tempol exhibited decreased monocyte/macrophage infiltration compared with untreated DOCA rats (16Ϯ3 and 26Ϯ4 versus 42Ϯ5; respectively, PϽ0.05) ( Figures 2B and 2C through 2E ), but the amount of infiltration was higher than for sham rats ( Figures  2A and 2C through 2E ). There was no significant difference in monocyte/macrophage infiltration in sham/Tempol or sham/PDTC rats compared with untreated sham rats (results not shown).
Using EMSAs, we identified an increase in NF-Bbinding activity in renal tissue from DOCA rats compared with sham rats (Figures 3A and 3C ). Treatment with PDTC or Tempol resulted in decreased NF-B-binding activity compared with untreated DOCA rats (Figures 3A through 3C) .
Treatment with PDTC also resulted in a significant decrease in NF-B-binding activity compared with sham rats (0.81Ϯ0.12-versus 1.0-fold) ( Figures 3A and 3B ). There was no significant difference in binding activity between DOCA/ Tempol-treated animals and sham animals ( Figure 3B ). As control, DOCA-salt hypertensive rat renal extracts were incubated with antibodies against NF-B subunits anti-p50 and anti-p65. Supershift assay confirmed p65 and p50 binding activity ( Figure 3C ).
Discussion
Several recent studies 3, 11, 14 have provided convincing evidence that hypertension causes increased ROS accumulation. Other studies have also shown that ROS cause activation of NF-B. 6,9 NF-B plays a critical role in the activation of multiple genes that contribute to the inflammatory response and end-organ damage. 13 Here, we report increased NF-B activation as well as increased ROS accumulation in the mineralocorticoid hypertensive rat. We tested the hypothesis that prolonged antioxidant administration inhibits superoxide accumulation, lowers blood pressure, and reduces NF-B activation in mineralocorticoid hypertensive rats. We found that antioxidants lower blood pressure, normalize O 2 Ϫ production, reduce NF-B activation, and reduce monocyte/macrophage infiltration. Furthermore, although we found that antioxidants reduce NF-B activation and normalize O 2 Ϫ production, they only partially correct the elevated systolic blood pressure and monocyte/macrophage infiltration. Thus, it is likely that other mechanisms, not yet fully identified, are participating in the hemodynamics and renal disturbances.
Previous studies have been shown that Ang II-induced hypertension cause renal hypertrophy, NF-B activation, adhesion molecule upregulation, and monocyte/macrophage infiltration. 14 Our findings in this low-renin model of hypertension suggests that NF-B activation and monocyte/macrophage infiltration may be due to locally produced cellular changes that result in ROS formation. Previously, it has been shown that Ang II, thrombin, platelet-derived growth factor, tumor necrosis factor-␣, and lactosylceramide increase NAD(P)H oxidase activity, thus resulting in superoxide accumulation. [27] [28] [29] Moreover, local cellular changes observed in mineralocorticoid hypertension could also be manifested through the stimulation of NAD(P)H oxidase. Therefore, further studies to better understand the mechanism by which superoxide is generated in the mineralocorticoid hypertensive rat are necessary.
Both superoxide and NO are highly reactive unstable free radicals that react together very rapidly to form peroxynitrate. 26 This reaction occurs 3 times faster than the dismutation of superoxide by SOD, thus implying that superoxide generation in vascular tissue may inhibit the physiological function of NO. 26 Also, it has been shown that experimental elevation of blood pressure and essential hypertension cause increased superoxide formation and decreased endotheliumdependent relaxation. 11, 19 Therefore, increased vascular O 2 Ϫ production observed in the aorta of the mineralocorticoid hypertensive rats may result in alteration in vascular endothelium-dependent relaxation due to decreased NO bioavailability.
Salt retention is characteristic of human hypertension and can be achieved rapidly in the mineralocorticoid hypertensive rat model. We chose to use the mineralocorticoid hypertensive rat model because it shows a markedly depressed renin-angiotensin system and because circulating Ang II has previously been shown to increase monocyte/macrophage infiltration and vasculopathy in the kidney and elsewhere. 13 In other studies, it has also been shown that increased vascular resistance due to arterial hypertension in humans results in increased intrarenal vascular resistance, which causes renal ischemia leading to renal damage. 30 , 31 The present study shows that long-term hypertension in the presence of low renin can cause induction in the renal inflammatory response, resulting from ROS accumulation and NF-B activation. To examine the pathogenesis caused by ROS accumulation, we used 2 potent antioxidants: PDTC and Tempol. From the results obtained in this study, PDTC appears to be a more potent antioxidant than Tempol, and the ability of PDTC to cause complete inhibition of the inflammatory response may be due to more than just its antioxidant effect. Therefore, further studies are necessary to discern some of these effects.
In conclusion, our results indicate that prolonged antioxidant administration normalizes superoxide accumulation, lowers systolic blood pressure, and reduces NF-B activation in mineralocorticoid hypertensive rats. Also, our results suggest that many of the renal changes that occur during hypertension may be due in part to the induction of signal transduction precursors that initiate the inflammatory response. Therefore, further studies to identify the pathophysiological implication of these precursors on the hypertensive state are necessary.
